Education
About Us
Working with TipRanks
Follow Us
iHuman (IH)
NYSE:IH
Total Valuation
iHuman has a market cap or net worth of $113.08M. The enterprise value is -$66.87M.
Market Cap$113.08M
Enterprise Value-$66.87M
Share Statistics
iHuman has 23,216,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding23,216,840
Owned by Insiders―
Owned by Institutions5.23%
Financial Efficiency
iHuman’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 14.85%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)14.85%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee1.30M
Profits Per Employee231.04K
Employee Count783
Asset Turnover0.70
Inventory Turnover17.97
Valuation Ratios
The current PE Ratio of iHuman is 6.73. iHuman’s PEG ratio is 0.11.
PE Ratio6.73
PS Ratio1.02
PB Ratio1.27
Price to Fair Value1.27
Price to FCF7.35
Price to Operating Cash Flow7.08
PEG Ratio0.11
Income Statement
In the last 12 months, iHuman had revenue of 1.02B and earned 180.91M in profits. Earnings per share was 0.66.
Revenue1.02B
Gross Profit721.27M
Operating Income159.89M
Pretax Income202.57M
Net Income180.91M
EBITDA171.58M
Earnings Per Share (EPS)0.66
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
iHuman pays an annual dividend of $0.085, resulting in a dividend yield of ―
Dividend Per Share$0.085
Dividend Yield―
Payout Ratio33.86%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change31.52%
50-Day Moving Average2.08
200-Day Moving Average1.74
Relative Strength Index (RSI)56.68
Average Volume (3m)64.26K
Important Dates
iHuman upcoming earnings date is Jun 18, 2025, TBA Not Confirmed.
Last Earnings DateMar 25, 2025
Next Earnings DateJun 18, 2025
Ex-Dividend DateApr 17, 2025
Financial Position
iHuman as a current ratio of 2.82, with Debt / Equity ratio of 0.26%
Current Ratio2.82
Quick Ratio2.78
Debt to Market Cap0.00
Net Debt to EBITDA-7.05
Interest Coverage Ratio0.00
Taxes
In the past 12 months, iHuman has paid 21.67M in taxes.
Income Tax21.67M
Effective Tax Rate0.11
Enterprise Valuation
iHuman EV to EBITDA ratio is 28.44, with an EV/FCF ratio of 29.46.
EV to Sales4.79
EV to EBITDA28.44
EV to Free Cash Flow29.46
EV to Operating Cash Flow28.35
Balance Sheet
iHuman has $1.17B in cash and marketable securities with ¥6.61M in debt, giving a net cash position of -$1.17B billion.
Cash & Marketable Securities$1.17B
Total Debt¥6.61M
Net Cash-$1.17B
Net Cash Per Share-$50.23
Tangible Book Value Per Share$3.41
Margins
Gross margin is 70.42%, with operating margin of 15.70%, and net profit margin of 17.77%.
Gross Margin70.42%
Operating Margin15.70%
Pretax Margin19.90%
Net Profit Margin17.77%
EBITDA Margin16.85%
EBIT Margin15.70%
Analyst Forecast
The average price target for iHuman is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-10.54%
EPS Growth Forecast-43.28%